AQST Dividend History & Analysis | N/A Yield

AQST has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of October 2025, Aquestive Therapeutics (AQST) does not pay a dividend.

Top Dividend Payers in Pharmaceuticals

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
SIGA 598 M 7.22% 12.6%
PFE 140,547 M 8.81% 7.89%
OGN 1,648 M 9.13% 2.20%
BMY 89,213 M 5.44% 5.06%
TAK 44,447 M 4.99% 5.19%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (CAGR) Payout Consistency
RPRX 21,583 M 29.4% 100%
ZTS 63,490 M 21.2% 100%
LLY 739,980 M 15.1% 99.5%
SIGA 598 M 15.5% 98.8%
RDY 12,030 M 28.0% 87.3%

Similar Stocks with Attractive Dividends - Compare AQST Dividends with its Peer-Group

SIGA
RPRX
Royalty Pharma
2.95% Yield
MRK
Merck
3.76% Yield
NVO
Novo Nordisk
3.37% Yield
SAN
Sanofi
4.45% Yield
JNJ

AQST Dividend History: as of October 2025

No dividends paid yet.

AQST Dividend FAQ

Aquestive Therapeutics, Inc. (NASDAQ:AQST) is a U.S.-based pharmaceutical company that develops and commercializes buccal and sublingual film drug delivery technologies for central nervous system (CNS) and other indications.

What is the Dividend Yield of AQST?

As of October 2025, AQST`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 6.66.

Does AQST pay a dividend?

As of October 2025 AQST does not pay a dividend.

How often does AQST pay dividends?

Over the last 12 months, AQST has issued dividend payments.

Will AQST pay dividends in 2025?

The next Ex-Dividend date for Aquestive Therapeutics (AQST) is currently unknown.

What is the next Ex-Dividend Date for AQST?

The next Ex-Dividend date for Aquestive Therapeutics (AQST) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of AQST?

AQST's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of AQST?

AQST's 5-Year Yield on Cost is -%. If you bought AQST's shares at 4.80 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of AQST?

AQST Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does AQST have a good Dividend Yield?

AQST`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of AQST?

The Dividend Payout Ratio of AQST is unknown.

What is the Dividend Rating of AQST?

AQST`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

AQST Outstanding Shares Analysis

What is the Trend in AQST`s Outstanding Shares (CAGR)?

Aquestive Therapeutics`s outstanding shares have increased by approximately 20.39% annually over the past 3 years (Correlation: 100.0%), negatively influencing the share price.

Has Aquestive Therapeutics ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Annual Growth Rate
2007 15,480,000
2017 20,000,000
2018 24,942,200 +24.71%
2019 26,435,800 +5.99%
2020 33,821,500 +27.94%
2021 40,391,500 +19.43%
2022 54,390,700 +34.66%
2023 68,533,100 +26%
2024 91,199,400 +33.07%
2025 99,326,700 +8.91%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid in the last 12m (TTM).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.

Last update: 2025-10-27 02:03